Retatrutide has emerged as a new medication in the fight against obesity. This novel drug, belonging to a dual GLP-1 and GIP receptor agonist, shows promising results in clinical trials. By activating these https://minarghz214364.loginblogin.com/43912990/tirzepatide-a-promising-new-treatment-for-obesity